235980 — Medpacto Balance Sheet
0.000.00%
- KR₩237bn
- KR₩195bn
Annual balance sheet for Medpacto, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Annual Audited Accounts | ARS | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 45,303 | 121,573 | 96,954 | 72,604 | 55,479 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 311 | 393 | 1,799 | 844 | 383 |
| Prepaid Expenses | |||||
| Total Current Assets | 49,024 | 126,085 | 100,331 | 75,154 | 56,790 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 3,317 | 2,563 | 5,203 | 3,647 | 2,789 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 58,496 | 133,346 | 107,687 | 80,474 | 60,785 |
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 2,464 | 978 | 72,799 | 7,741 | 1,375 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 2,753 | 89,803 | 75,365 | 9,566 | 3,042 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 55,743 | 43,543 | 32,323 | 70,909 | 57,743 |
| Total Liabilities & Shareholders' Equity | 58,496 | 133,346 | 107,687 | 80,474 | 60,785 |
| Total Common Shares Outstanding | |||||
| Total Preferred Shares Outstanding |